Sodium Zirconium Cyclosilicate among Individuals with Hyperkalemia
Oral sodium zirconium cyclosilicate (formerly ZS-9) binds and removes potassium via the gastrointestinal tract. Sodium zirconium cyclosilicate-associated restoration and maintenance of normokalemia and adverse events were evaluated in a two-part, open label, phase 3 trial.In the correction phase, ad...
Saved in:
| Main Authors: | , , , , , , , , , , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | 英语 |
| 出版: |
2019
|
| 在線閱讀: | https://doi.org/10.2215/cjn.12651018 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|